search
Back to results

THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death (THALES)

Primary Purpose

Acute Ischaemic Stroke, Transient Ischaemic Attack

Status
Completed
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Ticagrelor
Placebo
Sponsored by
AstraZeneca
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Ischaemic Stroke focused on measuring Acute ischaemic stroke; Transient Ischaemic Attack (TIA); Stroke

Eligibility Criteria

40 Years - 130 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Provision of signed informed consent prior to any study-specific procedure
  2. ≥40 years of age
  3. Acute onset of cerebral ischaemia due to

    1. AIS with NIHSS ≤5. AIS is defined as acute onset of neurological deficit attributed to focal brain ischaemia, and either of the following:

      • Persistent signs or symptoms of the ischaemic event at the time o randomisation, OR
      • Acute ischaemic brain lesion documented before randomisation by computed tomography (CT) scan or magnetic resonance imaging (MRI) (diffusion-weighted imaging) and that could account for the clinical presentation
    2. High-risk TIA, defined as neurological deficit of acute onset attributed to focal ischaemia of the brain by history or examination with complete resolution of the deficit, and at least one of the following:

      • ABCD2 score ≥6 and TIA symptoms not limited to isolated numbness, isolated visual changes, or isolated dizziness/vertigo
      • Symptomatic intracranial arterial occlusive disease that could account for the clinical presentation, documented by transcranial Doppler or vascular imaging and defined as at least 50% narrowing in the diameter of the vessel lumen
      • Internal carotid arterial occlusive disease that could account for the clinical presentation, documented by Doppler, ultrasound, or vascular imaging and defined as at least 50% narrowing in diameter of the vessel lumen
  4. Randomisation occurring within 24 hours after onset of symptoms; for wake-up strokes (when the time of symptom onset is not known), within 24 hours from the time point at which the patient was reported to be in their normal condition
  5. CT or MRI performed after symptom onset ruling out intracranial haemorrhage or other pathology, such as vascular malformation, tumour, or abscess that according

to the Investigator could explain symptoms or contraindicate study treatment

Exclusion Criteria:

  1. Need for or an anticipated need for any of the following:

    1. Dual antiplatelet therapy with ASA and P2Y12 inhibitors (including patients with carotid artery stenting and percutaneous coronary intervention)
    2. Antiplatelets other than ASA (eg, GPIIb/IIIa inhibitors, clopidogrel, ticlopidine, prasugrel, dipyridamole, ozagrel, cilostazol, ticagrelor) and other antithrombotic agents with antiplatelet effects, including traditional/herbal medicine agents
    3. Anticoagulants (eg, warfarin, oral thrombin and factor Xa inhibitors, bivalirudin, hirudin, argatroban, fondaparinux, or unfractionated heparin and long-term treatment with low-molecular weight heparins). Short-term treatment (≤7 days) with low-dose low-molecular weight heparin may be used in immobilised patients at the discretion of the Investigator
  2. Any history of atrial fibrillation/flutter, ventricular aneurysm, or suspicion of other cardioembolic pathology for TIA or stroke
  3. Patients who should receive or have received any intravenous or intra-arterial thrombolysis or mechanical thrombectomy within 24 hours prior to randomisation
  4. Planned carotid endarterectomy that requires halting investigational product within 3 days of randomisation or is expected to require unblinding of investigational product (planned carotid endarterectomy is in itself not an exclusion criterion)
  5. History of previous intracranial haemorrhage at any time (asymptomatic microbleeds do not qualify), gastrointestinal haemorrhage within the past 6 months, or major surgery within 30 days
  6. Patients considered to be at risk of bradycardic events (eg, known sick sinus syndrome or second- or third-degree atrioventricular block) unless already treated with a permanent pacemaker
  7. Inability of the patient to understand and/or comply with study procedures and/or follow-up, in the opinion of the Investigator
  8. Known hypersensitivity to ticagrelor or ASA
  9. Need for or an anticipated need for oral or intravenous therapy with any of the following:

    1. Strong cytochrome P450 3A (CYP3A4) inhibitors (eg, ketoconazole, clarithromycin [but not erythromycin or azithromycin], nefazadone, ritonavir, atazanavir) that cannot be stopped for the course of the study
    2. Long-term (>7 days) non-steroidal anti-inflammatory drugs
  10. Known bleeding diathesis or coagulation disorder (eg, thrombotic thrombocytopenic purpura)
  11. Known severe liver disease (eg, ascites or signs of coagulopathy)
  12. Renal failure requiring dialysis
  13. Pregnancy or breastfeeding. Women of child-bearing potential who are not willing to use a medically accepted method of contraception that is considered reliable in the judgment of the Investigator
  14. Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
  15. Previous enrolment or randomisation in the present study
  16. Participation in another clinical study with an investigational product at any time during the 30 days prior to randomisation (regardless of when treatment with the investigational product was discontinued)

Sites / Locations

  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

TICAGRELOR

TICAGRELOR PLACEBO

Arm Description

Outcomes

Primary Outcome Measures

Composite of Subsequent Stroke or Death
Participants with subsequent stroke or death

Secondary Outcome Measures

Ischaemic Stroke
Number of participants with ischaemic stroke
Number of Participants With Modified Rankin Scale (mRS) Score >1 at Visit 3
The modified Rankin Scale (mRS) is a scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. The scale runs from 0-6, running from perfect health without symptoms to death.0 - No symptoms,1 - No significant disability. Able to carry out all usual activities, despite some symptoms. 2 - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3 - Moderate disability. Requires some help, but able to walk unassisted. 4 - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5 - Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6 - Dead.

Full Information

First Posted
November 20, 2017
Last Updated
December 21, 2020
Sponsor
AstraZeneca
search

1. Study Identification

Unique Protocol Identification Number
NCT03354429
Brief Title
THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death
Acronym
THALES
Official Title
A Randomised, Double-Blind, Placebo-Controlled, International, Multicentre, Phase III Study to Investigate the Efficacy and Safety of Ticagrelor and ASA Compared With ASA in the Prevention of Stroke and Death in Patients With Acute Ischaemic Stroke or Transient Ischaemic Attack
Study Type
Interventional

2. Study Status

Record Verification Date
December 2020
Overall Recruitment Status
Completed
Study Start Date
January 22, 2018 (Actual)
Primary Completion Date
December 13, 2019 (Actual)
Study Completion Date
December 13, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
AstraZeneca

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Study to investigate if the study drug ticagrelor and ASA is more effective than Placebo (inactive tablet) and ASA in preventing new stroke events

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Ischaemic Stroke, Transient Ischaemic Attack
Keywords
Acute ischaemic stroke; Transient Ischaemic Attack (TIA); Stroke

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
11016 (Actual)

8. Arms, Groups, and Interventions

Arm Title
TICAGRELOR
Arm Type
Experimental
Arm Title
TICAGRELOR PLACEBO
Arm Type
Placebo Comparator
Intervention Type
Drug
Intervention Name(s)
Ticagrelor
Intervention Description
Ticagrelor arm: Day 1, loading dose of ticagrelor followed by daily maintenance dose until Day 30.
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Placebo arm: Day 1, loading dose of placebo followed by placebo daily maintenance dose until Day 30.
Primary Outcome Measure Information:
Title
Composite of Subsequent Stroke or Death
Description
Participants with subsequent stroke or death
Time Frame
From randomisation (day 1) to visit 3 (day 30-34)
Secondary Outcome Measure Information:
Title
Ischaemic Stroke
Description
Number of participants with ischaemic stroke
Time Frame
From randomisation (day 1) to visit 3 (day 30-34)
Title
Number of Participants With Modified Rankin Scale (mRS) Score >1 at Visit 3
Description
The modified Rankin Scale (mRS) is a scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. The scale runs from 0-6, running from perfect health without symptoms to death.0 - No symptoms,1 - No significant disability. Able to carry out all usual activities, despite some symptoms. 2 - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3 - Moderate disability. Requires some help, but able to walk unassisted. 4 - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5 - Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6 - Dead.
Time Frame
Visit 3 (day 30-34)
Other Pre-specified Outcome Measures:
Title
Bleeding Event That Fulfils Serious Adverse Event Criteria and is Categorised as GUSTO Severe
Description
Participants with bleeding event that fulfils serious adverse event criteria and is categorised as GUSTO Severe. GUSTO is a bleeding scale (GUSTO = Global Utilization of Streptokinase and Tissue plasminogen activator for Occluded coronary arteries). GUSTO Severe bleeding is defined as any of the following: (1) fatal bleeding, (2) intracranial bleeding, or (3) bleeding that caused haemodynamic compromise requiring intervention
Time Frame
From randomisation (day 1) to visit 3 (day 30-34)
Title
ICH or Fatal Bleeding Event
Description
Participants with ICH or fatal bleeding event
Time Frame
From randomisation (day 1) to visit 3 (day 30-34)
Title
Bleeding Event That Fulfils Serious Adverse Event Criteria and is Categorised as GUSTO Moderate/Severe
Description
Participants with bleeding event that fulfils serious adverse event criteria and is categorised as GUSTO Moderate/Severe. GUSTO is a bleeding scale (GUSTO = Global Utilization of Streptokinase and Tissue plasminogen activator for Occluded coronary arteries). GUSTO Severe bleeding is defined as any of the following: (1) fatal bleeding, (2) intracranial bleeding, or (3) bleeding that caused haemodynamic compromise requiring intervention. GUSTO Moderate bleeding is a bleeding requiring transfusion of whole blood or packed red blood cells without haemodynamic compromise
Time Frame
From randomisation (day 1) to visit 3 (day 30-34)
Title
Premature Permanent Discontinuation of IP Due to Bleeding
Description
Participants with premature permanent discontinuation of IP due to bleeding
Time Frame
From randomisation (day 1) to visit 3 (day 30-34)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
130 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Provision of signed informed consent prior to any study-specific procedure ≥40 years of age Acute onset of cerebral ischaemia due to AIS with NIHSS ≤5. AIS is defined as acute onset of neurological deficit attributed to focal brain ischaemia, and either of the following: Persistent signs or symptoms of the ischaemic event at the time o randomisation, OR Acute ischaemic brain lesion documented before randomisation by computed tomography (CT) scan or magnetic resonance imaging (MRI) (diffusion-weighted imaging) and that could account for the clinical presentation High-risk TIA, defined as neurological deficit of acute onset attributed to focal ischaemia of the brain by history or examination with complete resolution of the deficit, and at least one of the following: ABCD2 score ≥6 and TIA symptoms not limited to isolated numbness, isolated visual changes, or isolated dizziness/vertigo Symptomatic intracranial arterial occlusive disease that could account for the clinical presentation, documented by transcranial Doppler or vascular imaging and defined as at least 50% narrowing in the diameter of the vessel lumen Internal carotid arterial occlusive disease that could account for the clinical presentation, documented by Doppler, ultrasound, or vascular imaging and defined as at least 50% narrowing in diameter of the vessel lumen Randomisation occurring within 24 hours after onset of symptoms; for wake-up strokes (when the time of symptom onset is not known), within 24 hours from the time point at which the patient was reported to be in their normal condition CT or MRI performed after symptom onset ruling out intracranial haemorrhage or other pathology, such as vascular malformation, tumour, or abscess that according to the Investigator could explain symptoms or contraindicate study treatment Exclusion Criteria: Need for or an anticipated need for any of the following: Dual antiplatelet therapy with ASA and P2Y12 inhibitors (including patients with carotid artery stenting and percutaneous coronary intervention) Antiplatelets other than ASA (eg, GPIIb/IIIa inhibitors, clopidogrel, ticlopidine, prasugrel, dipyridamole, ozagrel, cilostazol, ticagrelor) and other antithrombotic agents with antiplatelet effects, including traditional/herbal medicine agents Anticoagulants (eg, warfarin, oral thrombin and factor Xa inhibitors, bivalirudin, hirudin, argatroban, fondaparinux, or unfractionated heparin and long-term treatment with low-molecular weight heparins). Short-term treatment (≤7 days) with low-dose low-molecular weight heparin may be used in immobilised patients at the discretion of the Investigator Any history of atrial fibrillation/flutter, ventricular aneurysm, or suspicion of other cardioembolic pathology for TIA or stroke Patients who should receive or have received any intravenous or intra-arterial thrombolysis or mechanical thrombectomy within 24 hours prior to randomisation Planned carotid endarterectomy that requires halting investigational product within 3 days of randomisation or is expected to require unblinding of investigational product (planned carotid endarterectomy is in itself not an exclusion criterion) History of previous intracranial haemorrhage at any time (asymptomatic microbleeds do not qualify), gastrointestinal haemorrhage within the past 6 months, or major surgery within 30 days Patients considered to be at risk of bradycardic events (eg, known sick sinus syndrome or second- or third-degree atrioventricular block) unless already treated with a permanent pacemaker Inability of the patient to understand and/or comply with study procedures and/or follow-up, in the opinion of the Investigator Known hypersensitivity to ticagrelor or ASA Need for or an anticipated need for oral or intravenous therapy with any of the following: Strong cytochrome P450 3A (CYP3A4) inhibitors (eg, ketoconazole, clarithromycin [but not erythromycin or azithromycin], nefazadone, ritonavir, atazanavir) that cannot be stopped for the course of the study Long-term (>7 days) non-steroidal anti-inflammatory drugs Known bleeding diathesis or coagulation disorder (eg, thrombotic thrombocytopenic purpura) Known severe liver disease (eg, ascites or signs of coagulopathy) Renal failure requiring dialysis Pregnancy or breastfeeding. Women of child-bearing potential who are not willing to use a medically accepted method of contraception that is considered reliable in the judgment of the Investigator Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site) Previous enrolment or randomisation in the present study Participation in another clinical study with an investigational product at any time during the 30 days prior to randomisation (regardless of when treatment with the investigational product was discontinued)
Facility Information:
Facility Name
Research Site
City
Adrogué
ZIP/Postal Code
1846
Country
Argentina
Facility Name
Research Site
City
Buenos Aires
ZIP/Postal Code
1180AAX
Country
Argentina
Facility Name
Research Site
City
Buenos Aires
ZIP/Postal Code
1437
Country
Argentina
Facility Name
Research Site
City
Buenos Aires
ZIP/Postal Code
AR-CP 1221
Country
Argentina
Facility Name
Research Site
City
Buenos Aires
ZIP/Postal Code
C1425 FSD
Country
Argentina
Facility Name
Research Site
City
Buenos Aires
ZIP/Postal Code
C1437BZK
Country
Argentina
Facility Name
Research Site
City
Capital Federal
ZIP/Postal Code
1428
Country
Argentina
Facility Name
Research Site
City
Ciudad Autónoma de Bs. As.
ZIP/Postal Code
C1199ABB
Country
Argentina
Facility Name
Research Site
City
Cordoba
ZIP/Postal Code
5000
Country
Argentina
Facility Name
Research Site
City
Mar del Plata
ZIP/Postal Code
B7602CBM
Country
Argentina
Facility Name
Research Site
City
Mendoza
ZIP/Postal Code
M5500IDN
Country
Argentina
Facility Name
Research Site
City
Rosario
ZIP/Postal Code
S2000DSV
Country
Argentina
Facility Name
Research Site
City
Rosario
ZIP/Postal Code
S200GAP
Country
Argentina
Facility Name
Research Site
City
Salta
ZIP/Postal Code
A4400
Country
Argentina
Facility Name
Research Site
City
Adelaide
ZIP/Postal Code
5000
Country
Australia
Facility Name
Research Site
City
Heidelberg
ZIP/Postal Code
3084
Country
Australia
Facility Name
Research Site
City
Herston
ZIP/Postal Code
4029
Country
Australia
Facility Name
Research Site
City
Parkville
ZIP/Postal Code
3050
Country
Australia
Facility Name
Research Site
City
Southport
ZIP/Postal Code
4215
Country
Australia
Facility Name
Research Site
City
St Albans
ZIP/Postal Code
3021
Country
Australia
Facility Name
Research Site
City
Antwerpen
ZIP/Postal Code
2020
Country
Belgium
Facility Name
Research Site
City
Assebroek (Brugge)
ZIP/Postal Code
8310
Country
Belgium
Facility Name
Research Site
City
Bruges
ZIP/Postal Code
8000
Country
Belgium
Facility Name
Research Site
City
Brussels
ZIP/Postal Code
1200
Country
Belgium
Facility Name
Research Site
City
Dendermonde
ZIP/Postal Code
9200
Country
Belgium
Facility Name
Research Site
City
Edegem
ZIP/Postal Code
2650
Country
Belgium
Facility Name
Research Site
City
Kortrijk
ZIP/Postal Code
8500
Country
Belgium
Facility Name
Research Site
City
Leuven
ZIP/Postal Code
3000
Country
Belgium
Facility Name
Research Site
City
Liège
ZIP/Postal Code
4000
Country
Belgium
Facility Name
Research Site
City
Oostende
ZIP/Postal Code
8400
Country
Belgium
Facility Name
Research Site
City
Roeselare
ZIP/Postal Code
8800
Country
Belgium
Facility Name
Research Site
City
Sint-Truiden
ZIP/Postal Code
3800
Country
Belgium
Facility Name
Research Site
City
Yvoir
ZIP/Postal Code
5530
Country
Belgium
Facility Name
Research Site
City
Botucatu
ZIP/Postal Code
18618-687
Country
Brazil
Facility Name
Research Site
City
Curitiba
ZIP/Postal Code
81210-310
Country
Brazil
Facility Name
Research Site
City
Goiania
ZIP/Postal Code
74083-100
Country
Brazil
Facility Name
Research Site
City
Joinville
ZIP/Postal Code
89202-165
Country
Brazil
Facility Name
Research Site
City
Maringa
ZIP/Postal Code
87015-000
Country
Brazil
Facility Name
Research Site
City
Porto Alegre
ZIP/Postal Code
90610-000
Country
Brazil
Facility Name
Research Site
City
Ribeirao Preto
ZIP/Postal Code
14015130
Country
Brazil
Facility Name
Research Site
City
Rio de Janeiro
ZIP/Postal Code
22270-005
Country
Brazil
Facility Name
Research Site
City
Salvador
ZIP/Postal Code
41820011
Country
Brazil
Facility Name
Research Site
City
Dupnitsa
ZIP/Postal Code
2600
Country
Bulgaria
Facility Name
Research Site
City
Kozloduy
ZIP/Postal Code
3320
Country
Bulgaria
Facility Name
Research Site
City
Lukovit
ZIP/Postal Code
5770
Country
Bulgaria
Facility Name
Research Site
City
Pazardzhik
ZIP/Postal Code
4400
Country
Bulgaria
Facility Name
Research Site
City
Pleven
ZIP/Postal Code
5800
Country
Bulgaria
Facility Name
Research Site
City
Sliven
ZIP/Postal Code
8800
Country
Bulgaria
Facility Name
Research Site
City
Sofia
ZIP/Postal Code
1142
Country
Bulgaria
Facility Name
Research Site
City
Sofia
ZIP/Postal Code
1407
Country
Bulgaria
Facility Name
Research Site
City
Sofia
ZIP/Postal Code
1606
Country
Bulgaria
Facility Name
Research Site
City
Teteven
ZIP/Postal Code
5700
Country
Bulgaria
Facility Name
Research Site
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T2N 2T9
Country
Canada
Facility Name
Research Site
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T6G 2B7
Country
Canada
Facility Name
Research Site
City
Lethbridge
State/Province
Alberta
ZIP/Postal Code
T1J 0N9
Country
Canada
Facility Name
Research Site
City
Chicoutimi
ZIP/Postal Code
G7H 5H6
Country
Canada
Facility Name
Research Site
City
Baoji
ZIP/Postal Code
721008
Country
China
Facility Name
Research Site
City
Baotou
ZIP/Postal Code
014016
Country
China
Facility Name
Research Site
City
Beijing
ZIP/Postal Code
100049
Country
China
Facility Name
Research Site
City
Beijing
ZIP/Postal Code
100070
Country
China
Facility Name
Research Site
City
Beijing
ZIP/Postal Code
100191
Country
China
Facility Name
Research Site
City
Changsha
ZIP/Postal Code
410013
Country
China
Facility Name
Research Site
City
Changsha
ZIP/Postal Code
410078
Country
China
Facility Name
Research Site
City
Changsha
ZIP/Postal Code
430033
Country
China
Facility Name
Research Site
City
Chifeng
ZIP/Postal Code
024000
Country
China
Facility Name
Research Site
City
Daqing
ZIP/Postal Code
163000
Country
China
Facility Name
Research Site
City
Foshan
ZIP/Postal Code
528000
Country
China
Facility Name
Research Site
City
Guangzhou
ZIP/Postal Code
510080
Country
China
Facility Name
Research Site
City
Guangzhou
ZIP/Postal Code
510180
Country
China
Facility Name
Research Site
City
Guangzhou
ZIP/Postal Code
510630
Country
China
Facility Name
Research Site
City
Guiyang
ZIP/Postal Code
550004
Country
China
Facility Name
Research Site
City
Haikou
ZIP/Postal Code
570311
Country
China
Facility Name
Research Site
City
Hangzhou
ZIP/Postal Code
310009
Country
China
Facility Name
Research Site
City
Hohhot
ZIP/Postal Code
010017
Country
China
Facility Name
Research Site
City
Hohhot
ZIP/Postal Code
10050
Country
China
Facility Name
Research Site
City
Jinan
ZIP/Postal Code
250001
Country
China
Facility Name
Research Site
City
Jinzhou
ZIP/Postal Code
121004
Country
China
Facility Name
Research Site
City
Liuzhou
ZIP/Postal Code
545006
Country
China
Facility Name
Research Site
City
Nanchang
ZIP/Postal Code
330006
Country
China
Facility Name
Research Site
City
Nanjing
ZIP/Postal Code
210029
Country
China
Facility Name
Research Site
City
Nantong
ZIP/Postal Code
226001
Country
China
Facility Name
Research Site
City
Ningbo
ZIP/Postal Code
315010
Country
China
Facility Name
Research Site
City
Shanghai
ZIP/Postal Code
200080
Country
China
Facility Name
Research Site
City
Shanghai
ZIP/Postal Code
200090
Country
China
Facility Name
Research Site
City
Shanghai
ZIP/Postal Code
CN-200120
Country
China
Facility Name
Research Site
City
Shenyang
ZIP/Postal Code
110016
Country
China
Facility Name
Research Site
City
Taiyuan
ZIP/Postal Code
030001
Country
China
Facility Name
Research Site
City
Tangshan
ZIP/Postal Code
063001
Country
China
Facility Name
Research Site
City
Tianjin
ZIP/Postal Code
300060
Country
China
Facility Name
Research Site
City
Tianjin
ZIP/Postal Code
300121
Country
China
Facility Name
Research Site
City
Wenzhou
ZIP/Postal Code
325000
Country
China
Facility Name
Research Site
City
Wu Han
ZIP/Postal Code
430060
Country
China
Facility Name
Research Site
City
Wuhan
ZIP/Postal Code
430022
Country
China
Facility Name
Research Site
City
Wuhan
ZIP/Postal Code
430033
Country
China
Facility Name
Research Site
City
Wuxi
ZIP/Postal Code
214002
Country
China
Facility Name
Research Site
City
Xi'an
ZIP/Postal Code
710061
Country
China
Facility Name
Research Site
City
Xiamen
ZIP/Postal Code
361004
Country
China
Facility Name
Research Site
City
Xining
ZIP/Postal Code
810001
Country
China
Facility Name
Research Site
City
Xuzhou
ZIP/Postal Code
221006
Country
China
Facility Name
Research Site
City
Brno
ZIP/Postal Code
656 91
Country
Czechia
Facility Name
Research Site
City
Chomutov
ZIP/Postal Code
430 12
Country
Czechia
Facility Name
Research Site
City
Ostrava
ZIP/Postal Code
703 84
Country
Czechia
Facility Name
Research Site
City
Ostrava
ZIP/Postal Code
708 52
Country
Czechia
Facility Name
Research Site
City
Pardubice
ZIP/Postal Code
520 03
Country
Czechia
Facility Name
Research Site
City
Praha 4
ZIP/Postal Code
140 59
Country
Czechia
Facility Name
Research Site
City
Usti nad Labem
ZIP/Postal Code
401 13
Country
Czechia
Facility Name
Research Site
City
Bayonne
ZIP/Postal Code
64100
Country
France
Facility Name
Research Site
City
Besancon Cedex
ZIP/Postal Code
25030
Country
France
Facility Name
Research Site
City
Bordeaux Cedex
ZIP/Postal Code
33076
Country
France
Facility Name
Research Site
City
Bourg en Bresse
ZIP/Postal Code
01012
Country
France
Facility Name
Research Site
City
Brest Cedex 2
ZIP/Postal Code
29609
Country
France
Facility Name
Research Site
City
Caen
ZIP/Postal Code
14033
Country
France
Facility Name
Research Site
City
Corbeil Essonnes Cedex
ZIP/Postal Code
91106
Country
France
Facility Name
Research Site
City
Dijon
ZIP/Postal Code
21079
Country
France
Facility Name
Research Site
City
Le Chesnay Cedex
ZIP/Postal Code
78157
Country
France
Facility Name
Research Site
City
Lille
ZIP/Postal Code
59037
Country
France
Facility Name
Research Site
City
Metz
ZIP/Postal Code
57085
Country
France
Facility Name
Research Site
City
Montpellier Cedex 5
ZIP/Postal Code
34295
Country
France
Facility Name
Research Site
City
Nancy
ZIP/Postal Code
54035
Country
France
Facility Name
Research Site
City
NICE Cedex 01
ZIP/Postal Code
06001
Country
France
Facility Name
Research Site
City
PARIS Cedex 12
ZIP/Postal Code
75571
Country
France
Facility Name
Research Site
City
Paris Cedex 13
ZIP/Postal Code
75651
Country
France
Facility Name
Research Site
City
Paris Cedex 18
ZIP/Postal Code
75877
Country
France
Facility Name
Research Site
City
Paris
ZIP/Postal Code
75019
Country
France
Facility Name
Research Site
City
Paris
ZIP/Postal Code
75475
Country
France
Facility Name
Research Site
City
Rennes
ZIP/Postal Code
35033
Country
France
Facility Name
Research Site
City
Rouen Cedex
ZIP/Postal Code
76031
Country
France
Facility Name
Research Site
City
Saint Herblain
ZIP/Postal Code
44093
Country
France
Facility Name
Research Site
City
Saint-Priez En Jarez
ZIP/Postal Code
42270
Country
France
Facility Name
Research Site
City
Strasbourg Cedex
ZIP/Postal Code
67098
Country
France
Facility Name
Research Site
City
Suresnes Cedex
ZIP/Postal Code
92151
Country
France
Facility Name
Research Site
City
Toulouse Cedex 9
ZIP/Postal Code
31059
Country
France
Facility Name
Research Site
City
Altenburg
ZIP/Postal Code
04600
Country
Germany
Facility Name
Research Site
City
Bad Neustadt
ZIP/Postal Code
97616
Country
Germany
Facility Name
Research Site
City
Berlin
ZIP/Postal Code
12351
Country
Germany
Facility Name
Research Site
City
Erlangen
ZIP/Postal Code
91054
Country
Germany
Facility Name
Research Site
City
Essen
ZIP/Postal Code
45147
Country
Germany
Facility Name
Research Site
City
Hamburg
ZIP/Postal Code
20099
Country
Germany
Facility Name
Research Site
City
Hamburg
ZIP/Postal Code
22043
Country
Germany
Facility Name
Research Site
City
Hamburg
ZIP/Postal Code
22291
Country
Germany
Facility Name
Research Site
City
Hamburg
ZIP/Postal Code
22763
Country
Germany
Facility Name
Research Site
City
Hannover
ZIP/Postal Code
30625
Country
Germany
Facility Name
Research Site
City
Minden
ZIP/Postal Code
32429
Country
Germany
Facility Name
Research Site
City
Münster
ZIP/Postal Code
48149
Country
Germany
Facility Name
Research Site
City
Hong Kong
Country
Hong Kong
Facility Name
Research Site
City
Kowloon
Country
Hong Kong
Facility Name
Research Site
City
Baja
ZIP/Postal Code
6500
Country
Hungary
Facility Name
Research Site
City
Balassagyarmat
ZIP/Postal Code
2660
Country
Hungary
Facility Name
Research Site
City
Budapest
ZIP/Postal Code
1083
Country
Hungary
Facility Name
Research Site
City
Budapest
ZIP/Postal Code
1106
Country
Hungary
Facility Name
Research Site
City
Budapest
ZIP/Postal Code
1125
Country
Hungary
Facility Name
Research Site
City
Budapest
ZIP/Postal Code
1134
Country
Hungary
Facility Name
Research Site
City
Budapest
ZIP/Postal Code
1204
Country
Hungary
Facility Name
Research Site
City
Debrecen
ZIP/Postal Code
4043
Country
Hungary
Facility Name
Research Site
City
Győr
ZIP/Postal Code
9000
Country
Hungary
Facility Name
Research Site
City
Kistarcsa
ZIP/Postal Code
2143
Country
Hungary
Facility Name
Research Site
City
Miskolc
ZIP/Postal Code
3526
Country
Hungary
Facility Name
Research Site
City
Nyíregyháza
ZIP/Postal Code
4400
Country
Hungary
Facility Name
Research Site
City
Pécs
ZIP/Postal Code
7623
Country
Hungary
Facility Name
Research Site
City
Sopron-Balf
ZIP/Postal Code
9494
Country
Hungary
Facility Name
Research Site
City
Székesfehérvár
ZIP/Postal Code
8000
Country
Hungary
Facility Name
Research Site
City
Tatabánya
ZIP/Postal Code
2800
Country
Hungary
Facility Name
Research Site
City
Bangalore
ZIP/Postal Code
560002
Country
India
Facility Name
Research Site
City
Bangalore
ZIP/Postal Code
560068
Country
India
Facility Name
Research Site
City
Bengaluru
ZIP/Postal Code
560076
Country
India
Facility Name
Research Site
City
Dehradun
ZIP/Postal Code
248001
Country
India
Facility Name
Research Site
City
Guntur
ZIP/Postal Code
522001
Country
India
Facility Name
Research Site
City
Gurgaon
ZIP/Postal Code
122001
Country
India
Facility Name
Research Site
City
Gurgaon
ZIP/Postal Code
122002
Country
India
Facility Name
Research Site
City
Hyderabad
ZIP/Postal Code
500018
Country
India
Facility Name
Research Site
City
Kanpur
ZIP/Postal Code
208002
Country
India
Facility Name
Research Site
City
Kolkata
ZIP/Postal Code
700017
Country
India
Facility Name
Research Site
City
Mangalore
ZIP/Postal Code
575002
Country
India
Facility Name
Research Site
City
Nagpur
ZIP/Postal Code
420012
Country
India
Facility Name
Research Site
City
Nagpur
ZIP/Postal Code
440012
Country
India
Facility Name
Research Site
City
Nashik
ZIP/Postal Code
422005
Country
India
Facility Name
Research Site
City
New Delhi
ZIP/Postal Code
110005
Country
India
Facility Name
Research Site
City
New Delhi
ZIP/Postal Code
110026
Country
India
Facility Name
Research Site
City
New Delhi
ZIP/Postal Code
110029
Country
India
Facility Name
Research Site
City
Srikakulam
ZIP/Postal Code
532001
Country
India
Facility Name
Research Site
City
Varanasi
ZIP/Postal Code
221004
Country
India
Facility Name
Research Site
City
Cona
ZIP/Postal Code
44124
Country
Italy
Facility Name
Research Site
City
Genova
ZIP/Postal Code
16128
Country
Italy
Facility Name
Research Site
City
Genova
ZIP/Postal Code
16132
Country
Italy
Facility Name
Research Site
City
Massa
ZIP/Postal Code
55100
Country
Italy
Facility Name
Research Site
City
Milano
ZIP/Postal Code
20132
Country
Italy
Facility Name
Research Site
City
Modena
ZIP/Postal Code
41100
Country
Italy
Facility Name
Research Site
City
Negrar
ZIP/Postal Code
37024
Country
Italy
Facility Name
Research Site
City
Pavia
ZIP/Postal Code
27100
Country
Italy
Facility Name
Research Site
City
Perugia
ZIP/Postal Code
06132
Country
Italy
Facility Name
Research Site
City
Pietra Ligure
ZIP/Postal Code
17027
Country
Italy
Facility Name
Research Site
City
Pisa
ZIP/Postal Code
56100
Country
Italy
Facility Name
Research Site
City
Roma
ZIP/Postal Code
00144
Country
Italy
Facility Name
Research Site
City
Roma
ZIP/Postal Code
00152
Country
Italy
Facility Name
Research Site
City
Roma
ZIP/Postal Code
00161
Country
Italy
Facility Name
Research Site
City
Siena
ZIP/Postal Code
53100
Country
Italy
Facility Name
Research Site
City
Varese
ZIP/Postal Code
21100
Country
Italy
Facility Name
Research Site
City
Verona
ZIP/Postal Code
37126
Country
Italy
Facility Name
Research Site
City
Vicenza
ZIP/Postal Code
36100
Country
Italy
Facility Name
Research Site
City
Vizzolo Predabissi
ZIP/Postal Code
20070
Country
Italy
Facility Name
Research Site
City
Anyang-si
ZIP/Postal Code
14068
Country
Korea, Republic of
Facility Name
Research Site
City
Busan
ZIP/Postal Code
49201
Country
Korea, Republic of
Facility Name
Research Site
City
Busan
ZIP/Postal Code
49241
Country
Korea, Republic of
Facility Name
Research Site
City
Cheongju-si
ZIP/Postal Code
28644
Country
Korea, Republic of
Facility Name
Research Site
City
Daegu
ZIP/Postal Code
42415
Country
Korea, Republic of
Facility Name
Research Site
City
Daegu
ZIP/Postal Code
42601
Country
Korea, Republic of
Facility Name
Research Site
City
Daegu
ZIP/Postal Code
700-721
Country
Korea, Republic of
Facility Name
Research Site
City
Daejeon-si
ZIP/Postal Code
35233
Country
Korea, Republic of
Facility Name
Research Site
City
Goyang-si
ZIP/Postal Code
411-706
Country
Korea, Republic of
Facility Name
Research Site
City
Gwangju
ZIP/Postal Code
61469
Country
Korea, Republic of
Facility Name
Research Site
City
Incheon
ZIP/Postal Code
400-711
Country
Korea, Republic of
Facility Name
Research Site
City
Jeju-do
ZIP/Postal Code
63241
Country
Korea, Republic of
Facility Name
Research Site
City
Seongnam-si
ZIP/Postal Code
13620
Country
Korea, Republic of
Facility Name
Research Site
City
Seoul
ZIP/Postal Code
01830
Country
Korea, Republic of
Facility Name
Research Site
City
Seoul
ZIP/Postal Code
02053
Country
Korea, Republic of
Facility Name
Research Site
City
Seoul
ZIP/Postal Code
02447
Country
Korea, Republic of
Facility Name
Research Site
City
Seoul
ZIP/Postal Code
04401
Country
Korea, Republic of
Facility Name
Research Site
City
Culiacan
ZIP/Postal Code
80230
Country
Mexico
Facility Name
Research Site
City
D.F
ZIP/Postal Code
14269
Country
Mexico
Facility Name
Research Site
City
Durango
ZIP/Postal Code
34217
Country
Mexico
Facility Name
Research Site
City
Guadalajara
ZIP/Postal Code
44280
Country
Mexico
Facility Name
Research Site
City
Mexico City
ZIP/Postal Code
07760
Country
Mexico
Facility Name
Research Site
City
Mexico City
ZIP/Postal Code
6726
Country
Mexico
Facility Name
Research Site
City
Mexico
ZIP/Postal Code
01090
Country
Mexico
Facility Name
Research Site
City
Monterrey
ZIP/Postal Code
64460
Country
Mexico
Facility Name
Research Site
City
México
ZIP/Postal Code
03103
Country
Mexico
Facility Name
Research Site
City
Tijuana
ZIP/Postal Code
22321
Country
Mexico
Facility Name
Research Site
City
Bellavista
ZIP/Postal Code
CALLAO 2
Country
Peru
Facility Name
Research Site
City
Callao
ZIP/Postal Code
CALLAO 02
Country
Peru
Facility Name
Research Site
City
Lima
ZIP/Postal Code
LIMA 01
Country
Peru
Facility Name
Research Site
City
Lima
ZIP/Postal Code
LIMA 13
Country
Peru
Facility Name
Research Site
City
Lima
ZIP/Postal Code
LIMA 1
Country
Peru
Facility Name
Research Site
City
Lima
ZIP/Postal Code
LIMA 31
Country
Peru
Facility Name
Research Site
City
Lima
ZIP/Postal Code
Lima-1
Country
Peru
Facility Name
Research Site
City
Trujillo
ZIP/Postal Code
130101
Country
Peru
Facility Name
Research Site
City
Urb. El Chipe
ZIP/Postal Code
20007
Country
Peru
Facility Name
Research Site
City
Białystok
ZIP/Postal Code
15-276
Country
Poland
Facility Name
Research Site
City
Chełm
ZIP/Postal Code
22-100
Country
Poland
Facility Name
Research Site
City
Działdowo
ZIP/Postal Code
13-200
Country
Poland
Facility Name
Research Site
City
Gdańsk
ZIP/Postal Code
80-803
Country
Poland
Facility Name
Research Site
City
Gdańsk
ZIP/Postal Code
80-952
Country
Poland
Facility Name
Research Site
City
Grodzisk Mazowiecki
ZIP/Postal Code
05-825
Country
Poland
Facility Name
Research Site
City
Gryfice
ZIP/Postal Code
72-300
Country
Poland
Facility Name
Research Site
City
Katowice
ZIP/Postal Code
40-635
Country
Poland
Facility Name
Research Site
City
Końskie
ZIP/Postal Code
26-200
Country
Poland
Facility Name
Research Site
City
Kraków
ZIP/Postal Code
31-826
Country
Poland
Facility Name
Research Site
City
Lublin
ZIP/Postal Code
20-954
Country
Poland
Facility Name
Research Site
City
Olsztyn
ZIP/Postal Code
10-082
Country
Poland
Facility Name
Research Site
City
Olsztyn
ZIP/Postal Code
10-560
Country
Poland
Facility Name
Research Site
City
Ostrołęka
ZIP/Postal Code
07-410
Country
Poland
Facility Name
Research Site
City
Rybnik
ZIP/Postal Code
44-200
Country
Poland
Facility Name
Research Site
City
Sandomierz
ZIP/Postal Code
27-600
Country
Poland
Facility Name
Research Site
City
Skarżysko-Kamienna
ZIP/Postal Code
26-110
Country
Poland
Facility Name
Research Site
City
Warszawa
ZIP/Postal Code
02-957
Country
Poland
Facility Name
Research Site
City
Warszawa
ZIP/Postal Code
03-242
Country
Poland
Facility Name
Research Site
City
Zielona Góra
ZIP/Postal Code
65-046
Country
Poland
Facility Name
Research Site
City
Łódź
ZIP/Postal Code
90-153
Country
Poland
Facility Name
Research Site
City
Łódź
ZIP/Postal Code
93-113
Country
Poland
Facility Name
Research Site
City
Świebodzin
ZIP/Postal Code
66-200
Country
Poland
Facility Name
Research Site
City
Bucharest
ZIP/Postal Code
011461
Country
Romania
Facility Name
Research Site
City
Bucharest
ZIP/Postal Code
020125
Country
Romania
Facility Name
Research Site
City
Bucharest
ZIP/Postal Code
050098
Country
Romania
Facility Name
Research Site
City
Iasi
ZIP/Postal Code
700309
Country
Romania
Facility Name
Research Site
City
Oradea
ZIP/Postal Code
410169
Country
Romania
Facility Name
Research Site
City
Sibiu
ZIP/Postal Code
550166
Country
Romania
Facility Name
Research Site
City
Timisoara
ZIP/Postal Code
300736
Country
Romania
Facility Name
Research Site
City
Tirgu-Mures
ZIP/Postal Code
540136
Country
Romania
Facility Name
Research Site
City
Chelyabinsk
ZIP/Postal Code
454106
Country
Russian Federation
Facility Name
Research Site
City
Ekaterinburg
ZIP/Postal Code
620102
Country
Russian Federation
Facility Name
Research Site
City
Izhevsk
ZIP/Postal Code
426063
Country
Russian Federation
Facility Name
Research Site
City
Kazan
ZIP/Postal Code
420012
Country
Russian Federation
Facility Name
Research Site
City
Kazan
ZIP/Postal Code
420101
Country
Russian Federation
Facility Name
Research Site
City
Kemerovo
ZIP/Postal Code
650002
Country
Russian Federation
Facility Name
Research Site
City
Moscow
ZIP/Postal Code
109004
Country
Russian Federation
Facility Name
Research Site
City
Moscow
ZIP/Postal Code
115516
Country
Russian Federation
Facility Name
Research Site
City
Moscow
ZIP/Postal Code
117292
Country
Russian Federation
Facility Name
Research Site
City
Moscow
ZIP/Postal Code
117997
Country
Russian Federation
Facility Name
Research Site
City
Moscow
ZIP/Postal Code
121374
Country
Russian Federation
Facility Name
Research Site
City
Moscow
ZIP/Postal Code
123367
Country
Russian Federation
Facility Name
Research Site
City
Nizhnii Novgorod
ZIP/Postal Code
603018
Country
Russian Federation
Facility Name
Research Site
City
Nizhniy Novgorod
ZIP/Postal Code
603005
Country
Russian Federation
Facility Name
Research Site
City
Novosibirsk
ZIP/Postal Code
630003
Country
Russian Federation
Facility Name
Research Site
City
Novosibirsk
ZIP/Postal Code
630051
Country
Russian Federation
Facility Name
Research Site
City
Ryazan
ZIP/Postal Code
390039
Country
Russian Federation
Facility Name
Research Site
City
Saint Petersburg
ZIP/Postal Code
196247
Country
Russian Federation
Facility Name
Research Site
City
Saint Petersburg
ZIP/Postal Code
196601
Country
Russian Federation
Facility Name
Research Site
City
Saint-Petersburg
ZIP/Postal Code
192242
Country
Russian Federation
Facility Name
Research Site
City
Saint-Petersburg
ZIP/Postal Code
194354
Country
Russian Federation
Facility Name
Research Site
City
Samara
ZIP/Postal Code
443095
Country
Russian Federation
Facility Name
Research Site
City
Samara
ZIP/Postal Code
443096
Country
Russian Federation
Facility Name
Research Site
City
Saratov
ZIP/Postal Code
410030
Country
Russian Federation
Facility Name
Research Site
City
Sochi
ZIP/Postal Code
354057
Country
Russian Federation
Facility Name
Research Site
City
Tomsk
ZIP/Postal Code
634063
Country
Russian Federation
Facility Name
Research Site
City
Ufa
ZIP/Postal Code
450071
Country
Russian Federation
Facility Name
Research Site
City
Voronezh
ZIP/Postal Code
394066
Country
Russian Federation
Facility Name
Research Site
City
Yaroslavl
ZIP/Postal Code
150030
Country
Russian Federation
Facility Name
Research Site
City
Ar Riyāḑ
ZIP/Postal Code
11426
Country
Saudi Arabia
Facility Name
Research Site
City
Jeddah
ZIP/Postal Code
21423
Country
Saudi Arabia
Facility Name
Research Site
City
Riyadh
ZIP/Postal Code
11525
Country
Saudi Arabia
Facility Name
Research Site
City
Riyadh
ZIP/Postal Code
12372
Country
Saudi Arabia
Facility Name
Research Site
City
Dolny Kubin
ZIP/Postal Code
02614
Country
Slovakia
Facility Name
Research Site
City
Levoca
ZIP/Postal Code
054 01
Country
Slovakia
Facility Name
Research Site
City
Liptovsky Mikulas
ZIP/Postal Code
031 23
Country
Slovakia
Facility Name
Research Site
City
Martin
ZIP/Postal Code
03659
Country
Slovakia
Facility Name
Research Site
City
Nitra
ZIP/Postal Code
949 01
Country
Slovakia
Facility Name
Research Site
City
Rimavska Sobota
ZIP/Postal Code
97912
Country
Slovakia
Facility Name
Research Site
City
Skalica
ZIP/Postal Code
909 82
Country
Slovakia
Facility Name
Research Site
City
Spisska Nova Ves
ZIP/Postal Code
052 01
Country
Slovakia
Facility Name
Research Site
City
Trencin
ZIP/Postal Code
81171
Country
Slovakia
Facility Name
Research Site
City
Trnava
ZIP/Postal Code
91701
Country
Slovakia
Facility Name
Research Site
City
Ziar nad Hronom
ZIP/Postal Code
96537
Country
Slovakia
Facility Name
Research Site
City
Albacete
ZIP/Postal Code
02006
Country
Spain
Facility Name
Research Site
City
Alicante
ZIP/Postal Code
03010
Country
Spain
Facility Name
Research Site
City
Badalona(Barcelona)
ZIP/Postal Code
08916
Country
Spain
Facility Name
Research Site
City
Barcelona
ZIP/Postal Code
08003
Country
Spain
Facility Name
Research Site
City
Barcelona
ZIP/Postal Code
08025
Country
Spain
Facility Name
Research Site
City
Barcelona
ZIP/Postal Code
08035
Country
Spain
Facility Name
Research Site
City
Gerona
ZIP/Postal Code
17007
Country
Spain
Facility Name
Research Site
City
Lleida
ZIP/Postal Code
25198
Country
Spain
Facility Name
Research Site
City
Madrid
ZIP/Postal Code
28006
Country
Spain
Facility Name
Research Site
City
Madrid
ZIP/Postal Code
28034
Country
Spain
Facility Name
Research Site
City
Sevilla
ZIP/Postal Code
41009
Country
Spain
Facility Name
Research Site
City
Sevilla
ZIP/Postal Code
41013
Country
Spain
Facility Name
Research Site
City
Valencia
ZIP/Postal Code
46009
Country
Spain
Facility Name
Research Site
City
Valladolid
ZIP/Postal Code
47005
Country
Spain
Facility Name
Research Site
City
Zaragoza
ZIP/Postal Code
50009
Country
Spain
Facility Name
Research Site
City
Göteborg
ZIP/Postal Code
413 45
Country
Sweden
Facility Name
Research Site
City
Linköping
ZIP/Postal Code
581 85
Country
Sweden
Facility Name
Research Site
City
Lund
ZIP/Postal Code
221 85
Country
Sweden
Facility Name
Research Site
City
Malmö
ZIP/Postal Code
205 02
Country
Sweden
Facility Name
Research Site
City
Ostersund
ZIP/Postal Code
831 83
Country
Sweden
Facility Name
Research Site
City
Skövde
ZIP/Postal Code
541 85
Country
Sweden
Facility Name
Research Site
City
Solna
ZIP/Postal Code
171 76
Country
Sweden
Facility Name
Research Site
City
Stockholm
ZIP/Postal Code
118 83
Country
Sweden
Facility Name
Research Site
City
Stockholm
ZIP/Postal Code
182 88
Country
Sweden
Facility Name
Research Site
City
Uppsala
ZIP/Postal Code
751 85
Country
Sweden
Facility Name
Research Site
City
Changhua
ZIP/Postal Code
500
Country
Taiwan
Facility Name
Research Site
City
Kaohsiung City
ZIP/Postal Code
83301
Country
Taiwan
Facility Name
Research Site
City
Kaohsiung
ZIP/Postal Code
80756
Country
Taiwan
Facility Name
Research Site
City
Keelung
ZIP/Postal Code
20448
Country
Taiwan
Facility Name
Research Site
City
New Taipei City
ZIP/Postal Code
237
Country
Taiwan
Facility Name
Research Site
City
New Taipei
ZIP/Postal Code
23561
Country
Taiwan
Facility Name
Research Site
City
Taichung City
ZIP/Postal Code
437
Country
Taiwan
Facility Name
Research Site
City
Taichung
ZIP/Postal Code
40447
Country
Taiwan
Facility Name
Research Site
City
Taichung
ZIP/Postal Code
40705
Country
Taiwan
Facility Name
Research Site
City
Tainan
ZIP/Postal Code
704
Country
Taiwan
Facility Name
Research Site
City
Tainan
ZIP/Postal Code
710
Country
Taiwan
Facility Name
Research Site
City
Taipei
ZIP/Postal Code
10002
Country
Taiwan
Facility Name
Research Site
City
Taipei
ZIP/Postal Code
10449
Country
Taiwan
Facility Name
Research Site
City
Taipei
ZIP/Postal Code
11101
Country
Taiwan
Facility Name
Research Site
City
Taipei
ZIP/Postal Code
116
Country
Taiwan
Facility Name
Research Site
City
Taoyuan Hsien
ZIP/Postal Code
33305
Country
Taiwan
Facility Name
Research Site
City
Bangkok
ZIP/Postal Code
10220
Country
Thailand
Facility Name
Research Site
City
Bangkok
ZIP/Postal Code
10300
Country
Thailand
Facility Name
Research Site
City
Bangkok
ZIP/Postal Code
10330
Country
Thailand
Facility Name
Research Site
City
Bangkok
ZIP/Postal Code
10400
Country
Thailand
Facility Name
Research Site
City
Bangkok
ZIP/Postal Code
10600
Country
Thailand
Facility Name
Research Site
City
Bangkok
ZIP/Postal Code
10700
Country
Thailand
Facility Name
Research Site
City
Chonburi
ZIP/Postal Code
20000
Country
Thailand
Facility Name
Research Site
City
Hat Yai
ZIP/Postal Code
90110
Country
Thailand
Facility Name
Research Site
City
Khlong Luang
ZIP/Postal Code
12120
Country
Thailand
Facility Name
Research Site
City
Khon Kaen
ZIP/Postal Code
40002
Country
Thailand
Facility Name
Research Site
City
Lampang
ZIP/Postal Code
52000
Country
Thailand
Facility Name
Research Site
City
Muang
ZIP/Postal Code
57000
Country
Thailand
Facility Name
Research Site
City
Nakhonpathom
ZIP/Postal Code
73000
Country
Thailand
Facility Name
Research Site
City
Prachinburi
ZIP/Postal Code
25000
Country
Thailand
Facility Name
Research Site
City
Rajthevi
ZIP/Postal Code
10400
Country
Thailand
Facility Name
Research Site
City
Ratchaburi
ZIP/Postal Code
70000
Country
Thailand
Facility Name
Research Site
City
Ubonratchathani
ZIP/Postal Code
34000
Country
Thailand
Facility Name
Research Site
City
Chernivtsі
ZIP/Postal Code
58001
Country
Ukraine
Facility Name
Research Site
City
Ivano-Frankivsk
ZIP/Postal Code
76008
Country
Ukraine
Facility Name
Research Site
City
Ivano-Frankivsk
ZIP/Postal Code
76018
Country
Ukraine
Facility Name
Research Site
City
Kharkiv Region
ZIP/Postal Code
61018
Country
Ukraine
Facility Name
Research Site
City
Kharkiv Region
ZIP/Postal Code
61176
Country
Ukraine
Facility Name
Research Site
City
Kherson
ZIP/Postal Code
73000
Country
Ukraine
Facility Name
Research Site
City
Kyiv
ZIP/Postal Code
03129
Country
Ukraine
Facility Name
Research Site
City
Lutsk
ZIP/Postal Code
43024
Country
Ukraine
Facility Name
Research Site
City
Lviv
ZIP/Postal Code
79013
Country
Ukraine
Facility Name
Research Site
City
Poltava
ZIP/Postal Code
36038
Country
Ukraine
Facility Name
Research Site
City
Ternopil
ZIP/Postal Code
46027
Country
Ukraine
Facility Name
Research Site
City
Vinnytsia
ZIP/Postal Code
21005
Country
Ukraine
Facility Name
Research Site
City
Zaporizhzhia
ZIP/Postal Code
69068
Country
Ukraine
Facility Name
Research Site
City
Zaporizhzhia
ZIP/Postal Code
69600
Country
Ukraine
Facility Name
Research Site
City
Dong Nai
ZIP/Postal Code
81000
Country
Vietnam
Facility Name
Research Site
City
Ha Noi
ZIP/Postal Code
10000
Country
Vietnam
Facility Name
Research Site
City
Hanoi
ZIP/Postal Code
10000
Country
Vietnam
Facility Name
Research Site
City
Ho Chi Minh City
ZIP/Postal Code
70000
Country
Vietnam
Facility Name
Research Site
City
Ho Chi Minh
ZIP/Postal Code
70000
Country
Vietnam

12. IPD Sharing Statement

Citations:
PubMed Identifier
34477459
Citation
Johnston SC, Amarenco P, Aunes M, Denison H, Evans SR, Himmelmann A, Jahreskog M, James S, Knutsson M, Ladenvall P, Molina CA, Nylander S, Rother J, Wang Y; THALES Investigators. Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack. Stroke. 2021 Nov;52(11):3482-3489. doi: 10.1161/STROKEAHA.121.035555. Epub 2021 Sep 3.
Results Reference
derived
PubMed Identifier
34244703
Citation
Wang Y, Pan Y, Li H, Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Birve F, Ladenvall P, Molina CA, Johnston SC; THALES Steering Committee and Investigators. Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial. JAMA Neurol. 2021 Sep 1;78(9):1091-1098. doi: 10.1001/jamaneurol.2021.2440.
Results Reference
derived
PubMed Identifier
33940954
Citation
Yaghi S, de Havenon A, Rostanski S, Kvernland A, Mac Grory B, Furie KL, Kim AS, Easton JD, Johnston SC, Henninger N. Carotid Stenosis and Recurrent Ischemic Stroke: A Post-Hoc Analysis of the POINT Trial. Stroke. 2021 Jul;52(7):2414-2417. doi: 10.1161/STROKEAHA.121.034089. Epub 2021 May 4.
Results Reference
derived
PubMed Identifier
33198608
Citation
Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, Ladenvall P, Molina CA, Wang Y, Johnston SC; THALES Steering Committee and Investigators*. Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin. Stroke. 2020 Dec;51(12):3504-3513. doi: 10.1161/STROKEAHA.120.032239. Epub 2020 Nov 16.
Results Reference
derived
PubMed Identifier
33159526
Citation
Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, Ladenvall P, Molina CA, Wang Y, Johnston SC; THALES Steering Committee and Investigators. Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial. JAMA Neurol. 2020 Nov 7;78(2):1-9. doi: 10.1001/jamaneurol.2020.4396. Online ahead of print. Erratum In: JAMA Neurol. 2021 Feb 1;78(2):253.
Results Reference
derived
PubMed Identifier
32668111
Citation
Johnston SC, Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, Ladenvall P, Molina CA, Wang Y; THALES Investigators. Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. N Engl J Med. 2020 Jul 16;383(3):207-217. doi: 10.1056/NEJMoa1916870.
Results Reference
derived
PubMed Identifier
30747613
Citation
Johnston SC, Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, Ladenvall P, Molina CA, Wang Y; THALES Investigators. The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design. Int J Stroke. 2019 Oct;14(7):745-751. doi: 10.1177/1747493019830307. Epub 2019 Feb 12.
Results Reference
derived
PubMed Identifier
29915123
Citation
Wong KSL, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Himmelmann A, Kasner SE, Knutsson M, Ladenvall P, Minematsu K, Molina CA, Wang Y, Johnston SC; SOCRATES Steering Committee and Investigators. Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial. Stroke. 2018 Jul;49(7):1678-1685. doi: 10.1161/STROKEAHA.118.020553. Epub 2018 Jun 18.
Results Reference
derived
Links:
URL
https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&parentIdentifier=D5134C00003&attachmentIdentifier=3c773278-ed11-4f6a-ba36-6d927f39a776&fileName=d5134c00003_SAP_redacted.pdf&versionIdentifier=
Description
redacted SAP
URL
https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&parentIdentifier=D5134C00003&attachmentIdentifier=52098dc2-641a-49a8-8478-d745f5a10a26&fileName=d5134c00003_CSP_redacted.pdf&versionIdentifier=
Description
redacted CSP

Learn more about this trial

THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death

We'll reach out to this number within 24 hrs